Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2827857 | Blood Cells, Molecules, and Diseases | 2008 | 5 Pages |
Abstract
We established that in untreated Gaucher patients the prevalence of overweight is lower than in the general population. Long-term treatment with enzyme therapy induces a larger than average weight gain leading to a similar prevalence of overweight in enzyme therapy treated patients and the general population. The prevalence of type II diabetes increases significantly during treatment with enzyme therapy, resulting in a comparable prevalence of type II diabetes in enzyme therapy treated patients and the general population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
M. Langeveld, M.de Fost, J.M.F.G. Aerts, H.P. Sauerwein, C.E.M. Hollak,